NCT00457730View on ClinicalTrials.gov

A Study to Test the Use of Duloxetine for Pain in MS

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Multiple Sclerosis
Interventions
DRUG

Duloxetine

Patients will be randomly assigned to Duloxetine 30mg/d for 1 week, 60mg/d for 5 weeks and 30mg/d for 1 week or placebo for 7 weeks under double-blind conditions.

DRUG

Placebo

Subjects are randomized to either Duloxetine or Placebo

Trial Locations (1)

98034

Evergreen Healthcare, Kirkland

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Brown, Theodore R., M.D., MPH

INDIV

NCT00457730 - A Study to Test the Use of Duloxetine for Pain in MS | Biotech Hunter | Biotech Hunter